COVID-19: Features, clinical course and concerns

Parvaneh Darabi; Mehrdad Bagherpour kalo; Kosar Ali; Saeed Safari; Mahmoud Yousefifard; Mostafa Hosseini

doi:10.22037/jcma.v5i2.29885

Journal of Cellular & Molecular Anesthesia

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement New Publisher Announcement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v5i2.29885

COVID-19: Features, clinical course and concerns

Author(s):

Parvaneh Darabi^1,*,

Mehrdad Bagherpour kalo²,

Kosar Ali³,

Saeed Safari

⁴,

Mahmoud Yousefifard⁵,

Mostafa Hosseini

⁶

1Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

2Department of Epidemiology and Biostatistics, School of Public health Tehran University of Medical Sciences Tehran, Iran.

3Department of Medicine, College of Medicine, University of Sulaimani, Sulaimani, Iraq.

4Department of Emergency Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5Physiology Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

6Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Journal of Cellular & Molecular Anesthesia:Vol. 5, issue 2; e149613

Published online:May 07, 2020

Article type:Review

How to Cite:Parvaneh DarabiMehrdad Bagherpour kaloKosar AliSaeed SafariMahmoud YousefifardMostafa Hosseiniet al.COVID-19: Features, clinical course and concerns.J Cell Mol Anesth.5(2):e149613.https://doi.org/10.22037/jcma.v5i2.29885.

Abstract

The coronavirus disease 2019 (COVID-19) was first detected in December 2019 in Wuhan, China . So far, 136 reports from the WHO were reported. In the latest report, 6416828 patients in almost all countries have been infected with the COVID-19. The present study discusses the different aspects of COVID such as emergence, signs and symptoms, comparisons with SARS and MERS, concerns, governments' actions in controlling the virus and a descriptive analysis of the spread and death. The emergence of the coronavirus family in the last two decades has created a public health issue around the world. It has also caused serious damages to infrastructure, economy, culture and communities of countries. Thus, affected governments have taken steps to reduce these concerns such as quarantine, education, traffic control, closure of recreational centers, reduction of working hours etc. Despite strict measures to contain the COVID-19, this virus is still expanding and the question of "what actions should be taken with what political package?" is being asked. To answer this question, it is important to understand the process of disease occurrence and modeling different interventions on changing the natural course of the disease is very important

Keywords

COVID-19

Novel coronavirus

SARS-CoV-2

Coronavirus case fatality

MERS

SARS

References

1.
References are in the PDF file of the article.

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Parvaneh Darabi:[PubMed][Scholar]
Mehrdad Bagherpour kalo:[PubMed][Scholar]
Kosar Ali:[PubMed][Scholar]
Saeed Safari:[PubMed][Scholar]
Mahmoud Yousefifard:[PubMed][Scholar]
Mostafa Hosseini:[PubMed][Scholar]